Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-22

Clinical Trial Update: Membrane Blue Versus Infracyanine Green

View source ↗

Summary

Clinical trial comparing Membrane Blue versus Infracyanine Green for macular surgery has completed. The update covers dye efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infracyanine Green
  • Membrane Blue (membrane blue)

Snippet

Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Conditions: Macular Pucker, Macular Hole | Status: COMPLETED